goldennet

Non-invasive Prenatal Testing (NIPT)

All NIPT test items are certified by CAP international standards and analyzed using the exclusively patented GWNS algorithm. The entire process of checking babies' chromosomes is conducted in Taiwan, adhering to the most stringent and highest standard procedures to ensure accuracy and reliability.

SMA Genetic Testing

The carrier rate of Spinal Muscular Atrophy (SMA) is approximately 1 in 50. Genomics BioSci's SMA genetic testing is conducted in a TAF-certified laboratory registered for LDTs. With just a small blood sample, we can accurately determine genotype and carrier status

Fragile X Syndrome Genetic Testing

Fragile X Syndrome is a common genetic intellectual disorder. Genomics BioSci's Fragile X genetic testing is conducted in a TAF-certified laboratory registered for LDTs. By collecting a blood sample and extracting DNA, we can determine the FMR1 genotype of the test subject and assess their carrier status.

Microarray Assay

This assay utilizes the latest aCGH microarray chip, enhanced with probes specifically designed for detecting prenatal fetal genetic diseases in the Taiwanese population. It features up to 60,000 probes covering all 46 human chromosomes, with increased probe density in regions associated with known hereditary diseases, thereby enhancing analytical power.

PGS Preimplantation Genetic Screening

Whole-genome quantitative analysis using microarray technology, such as PGS testing, can prevent the implantation of embryos with abnormal chromosomes, thereby increasing the success rate of assisted reproduction.

Down Syndrome Risk Quadruple Test 2nd Trimester Screening

During the 15th to 20th week of pregnancy, a blood sample of 5 c.c. from the mother can be used to test the serum levels of four markers (AFP, b-HCG, Inhibin A, uE3) and assess the risk of the fetus having Down syndrome

Hereditary Hearing Loss Genetic Test

Through hereditary hearing loss genetic test, one can determine whether there are mutations in the common genes associated with hereditary hearing loss. This helps to identify whether the patient is a carrier of these genes and to assess the hereditary risk of hearing loss for future offspring.

Carrier Screening

This test is used to identify whether the patient carries recessive genes for certain hereditary diseases, determining if the person is a carrier of specific conditions. It helps to prevent the transmission of genetic mutations from parents to offspring, thereby reducing the risk of recessive diseases.